Clinical Study of Taurine Combined With Sintilimab and Chemotherapy for Treatment of Advanced Gastric Cancer
Status:
Recruiting
Trial end date:
2025-07-31
Target enrollment:
Participant gender:
Summary
This project aims to evaluate the efficacy and safety of oral taurine supplementation
combined with PD-1 inhibitor (sintilimab) and chemotherapy in inducing systemic CD8+ T cell
responses and achieving improved gastric cancer patient outcomes than with sintilimab and
chemotherapy alone.